Brief: Shanghai Bio-Heart Biological Technology Reports HY Total Comprehensive Loss Attributable RMB101.4 Mln05/08/2022 14:15
Brief: Shanghai Bio-Heart Biological Technology Says Unit To Buy 8.66% Stake In Shanghai Xinzhi Medical Technology21/06/2022 15:48
Brief: Shanghai Bio-Heart Biological Technology Contracts With CERC For European Clinical Trial For Iberis 2nd29/12/2021 15:17
Last trade - 00:00Last trade - 00:00Last trade - 00:00